Viewing Study NCT00169000


Ignite Creation Date: 2025-12-26 @ 12:16 PM
Ignite Modification Date: 2026-04-28 @ 8:21 PM
Study NCT ID: NCT00169000
Status: COMPLETED
Last Update Posted: 2009-08-06
First Post: 2005-09-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers
Sponsor: Dartmouth-Hitchcock Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None breast cancer View
None capecitabine View
None docetaxel View
None pharmacokinetic/pharmacodynamic View
None bcl-2 View
None bax View